Using Hawthorne effects to improve adherence in clinical practice: Lessons from clinical trials

JAMA Dermatology

Volumn 149, Issue 4, 2013, Pages 490-491

  Davis, Scott A ^a   Feldman, Steven R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; CALCIPOTRIOL; STEROID;

ACNE; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; DRUG SELF ADMINISTRATION; HAWTHORNE EFFECT; HUMAN; NOTE; PATIENT MONITORING; PRIORITY JOURNAL; PSORIASIS; SCALP PSORIASIS; SYSTEMIC THERAPY;

ANTI-INFLAMMATORY AGENTS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METHOTREXATE; PSORIASIS; ULTRAVIOLET THERAPY;

EID: 84876871307     PISSN: 21686068     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamadermatol.2013.2843     Document Type: Note

References (5)

1. Gelfand JM, Wan J, Callis Duffin K, et al. Comparative effectiveness of commonly used systemic treatments or phototherapy for moderate to severe plaque psoriasis in the clinical practice setting. Arch Dermatol. 2012;148(4):487-494.
2. Kragballe K, van de Kerkhof PC. Consistency of data in six phase III clinical studies of a two-compound product containing calcipotriol and betamethasone dipropionate ointment for the treatment of psoriasis. J Eur Acad Dermatol Venereol. 2006;20(1):39-44.
3. Bhosle MJ, Feldman SR, Camacho FT, Timothy Whitmire J, Nahata MC, Balkrishnan R. Medication adherence and health care costs associated with biologics in Medicaid-enrolled patients with psoriasis. J Dermatolog Treat. 2006;17(5):294-301. (Pubitemid 44595018)
4. Yentzer BA, Alikhan A, Teuschler H, et al. An exploratory study of adherence to topical benzoyl peroxide in patientswith acne vulgaris. J Am Acad Dermatol. 2009;60(5):879-880.
5. Yentzer BA, Wood AA, Sagransky MJ, et al. An Internet-based survey and improvement of acne treatment outcomes. Arch Dermatol. 2011;147(10):1223-1224.